Preview

Нефрология

Расширенный поиск

СОВРЕМЕННЫЕ КОНВЕКЦИОННЫЕ МЕТОДЫ ТЕРАПИИ БОЛЬНЫХ С ХРОНИЧЕСКОЙ ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ. СООБЩЕНИЕ II

https://doi.org/10.24884/1561-6274-2005-9-4-13-18

Полный текст:

Аннотация

Современные конвекционные методы терапии больных с хронической почечной недостаточностью. Сообщение II.

Об авторах

Н. Я. Губарь
Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
Россия

Кафедра пропедевтики внутренних болезней



А. В. Смирнов
Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
Россия

Кафедра пропедевтики внутренних болезней



Е. Д. Суглобова
Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
Россия

Кафедра пропедевтики внутренних болезней



Список литературы

1. Губарь НЯ, Смирнов АВ, Суглобова ЕД. Современные конвекционные методы терапии больных с хронической по чечной недостаточностью. Сообщение 1. Нефрология, 2005; 9(2):4248

2. Maggiore Q, Pizzarelli F, Dattolo P et al. Cardiovascular stability during haemodialysis, haemofiltration and haemodiafiltration. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 68–73

3. Pizzarelli F, Maggiore Q. Clinical perspectives of online haemodiafiltration. Nephrol Dial Transplant 1998; 13 [Suppl 5]: 34–37

4. Altieri P, Sorba G, Bolasco PG et al. Online predilution hemofiltration vs ultrapure highflux hemodialysis. Blood Purif 1997; 15:169181

5. Altieri P, Sorba G, Bolasco P et al. Predilution haemofiltration—the Sardinian multicentre studies: present and future. Nephrol Dial Transplant 2000; 15 [Suppl 2]: 55–59

6. Locatelli F, Mastrangelo F, Redaelli B et al. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. Kidney Int 1996; 50:12931302

7. Kissinger GL, Dellanna F, Upsing L et al. Homocysteine kinetics in postdilution hemodiafiltration with two different dialysate flow compared to hemodialysis. Nephrol Dial Transplant 2000; 15(9): A221

8. Nakanishi K, Hirasawa H, Sugai T et al. Efficacy of continuous hemodiafiltration for patient with congestive heart failure. Blood Purif 2002; 20(4): 342348

9. Maduell F, del Pozo1 C, Garcia H. Change from conventional haemodiafiltration to online haemodiafiltration. Nephrol Dial Transplant 1999; 14: 1202–1207

10. Рыбакова ОБ, Денисов АЮ, Шило ВЮ. Гемодиафиль трация в лечении терминальной стадии хронической по чечной недостаточности. Нефрология и диализ 2001; 3(4): 406410

11. Рыбакова ОБ, Денисов АЮ, Шило ВЮ. Эффектив ность гемодиализа и гемодиафильтрации online в лече нии анемии у больных с терминальной ХПН. Нефрология 2003; 7 [приложение 1]: 347

12. Lin CL, Huang CC, Yu CC et al. Improved iron utilization and reduced erythropoietin resistance by online hemodiafiltration. Blood Purif 2002; 20(4): 349356

13. Warren DJ, Otieno LS. Carpal tunnel syndrome in patients on intermittent haemodialysis. Postgrad Med J 1975; 51(597):4502

14. Gejyo F, Homma N, Suzuki Y, Arakawa M. Serum levels of beta 2microglobulin as a new form of amyloid protein in patients undergoing longterm hemodialysis. N Engl J Med 1986; 27(9):5856

15. Gejyo F, Odani S, Yamada T et al. Beta 2microglobulin: a new form of amyloid protein associated with chronic hemodialysis. Kidney Int 1986; 30(3): 38590

16. Gejyo F. Chronic renal failure: present and future. Pathophysiology and metabolic abnormalities—uremic toxin, middle and large molecular substances. Nippon Naika Gakkai Zasshi 1986; 75(11):15504

17. Drueke TB. b2Microglobulin and amyloidosis. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 17–24

18. Locatelli F, Di Filippo S, Manzoni C. Removal of small and middle molecules by convective techniques. Nephrol Dial Transplant 2000; 15 [Suppl 2]: 37–44

19. Lornoy W, Becaus I, Billiouw JM et al. Online haemodiafiltration. Remarkable removal of b2microglobulin. Longterm clinical observations. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 49–54

20. Nakai S, Iseki K, Tabei K et al. Outcomes of hemodiafiltration based on Japanese dialysis patient registry. Am J Kidney Dis 2001; 38 [Suppl. 1]: S212216

21. Locatelli F, Marucelli D, Conte F et al. Comparison of mortality in ESRD patient on convective and diffusive extracorporeal treatments. Kidney Int 1999; 155: 286293

22. Bricker NS, Slatopolsky E, Reiss E, Avioli LV. Calcium, phosphorus and bone in renal disease and transplantation. Arch Intern Med 1969; 123:543–553

23. Drueke TB. Renal osteodystrophy: management of hyperphosphataemia. Nephrol Dial Transplant 2000; 15, [Suppl. 5]: S32S34

24. Massry SG, Coburn JW, Hartenbower DL et al. Mineral content of human skin in uraemia. Effect of secondary hyperparathyroidism and haemodialysis. Proc Eur Dial Transplant Assoc 1970; 7: 146 148

25. Vanholder RC, Glorieux GL, De Smet RV. Uremic toxins: Removal with different therapies. Hemodial Int 2003; 7(2):162– 167

26. Vanholder RC, Glorieux GL, De Smet RV. Back to the future: middle molecules, high flux membranes, and optimal dialysis. Hemodial Int 2003; 7(1):52–57

27. Chanard J, Brunois IP, Melin JP et al. Longterm result of dialysis therapy with a highly permeable membrane. Artif Organs 1982; 6:261266

28. WoodsHF, Nandakumar M. Improved outcome for haemodialysis patients treated with highflux membranes. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 36–42

29. Locatelli F, Marucelli D, Conte F et al. Comparison of mortality in ESRD patient on convective and diffusive extracorporeal treatments. Kidney Int 1999; 155: 286293

30. Port FK, Wolfe RA, HulbertShearon TE et al. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: Results from the USRDS dialysis morbidity and mortality study. Am J Kidney Dis 2001; 37: 276286

31. Carlo Basile. The effect of convection on the nutritional status of haemodialysis patients. Nephrol Dial Transplant 2003; 18 [Suppl 7]: vii46–vii49

32. Gutierrez A, Bergstrom J, Alvestrand A. Protein catabolism in sham hemodialysis: the effect of different membranes. Clin Nephrol 1992; 38:2029

33. Locatelli F, Andrulli S, Pedrini L et al. Effect of highflux dialysis on the anemia of hemodialysis patients. Nephrol Dial Transplant 2000; 15:13991409

34. Locatelli F, Manzoni C, Di Filippo S, Andrulli S. Online monitoring and convective treatment modalities: shortterm advantages. Nephrol Dial Transplant 1999;14 [Suppl 3]: 927

35. Wizemann V, Lotz C, Techert F, Utho S. Online haemodiafiltration versus lowflux haemodialysis. A prospective randomized study. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 43–48

36. Locatelli F, Manzoni C, di Filippo S. The importance of convective transport. Kidney Int 2002; 61 [Suppl 80]: S115– S120

37. Cappelli G, Perrone S, CiuVreda A. Water quality for online haemodiafiltration. Nephrol Dial Transplant 1998; 13 [Suppl 5]: 12–16

38. Canaud B, Bosc JY, Leray H, Stec F. Microbiological purity of dialysate for online substitution fluid preparation. Nephrol Dial Transplant 2000; 15 [Suppl 2]: 21–30

39. Lonnemann G. Should ultrapure dialysate be mandatory? Nephrol Dial Transplant 2000; 15 [Suppl 1]: 55–59

40. Pontoriero G, Pozzoni P, Andrulli S, Locatelli F. The quality of dialysis water. Nephrol Dial Transplant 2003; 18 [Suppl 7]: vii21–vii25

41. Brunet P, Berland Y. Water quality and complications of haemodialysis. Nephrol Dial Transplant 2000; 15: 578580

42. Surian M, Bonforte G, Scanziani R et al. Trace elements and micropollutant anions in the dialysis and reinfusion fluid prepared online for haemodiafiltration. Nephrol Dial Transplant 1998; 13 [Suppl 5]: 24–28

43. Canaud B, Bosc JY, LerayMoragues H et al. Online haemodiafiltration. Safety and efficacy in longterm clinical practice. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 60–67

44. Combarnous F, Tetta C, Cellier CC et al. Albumin loss in online hemodiafiltration. Int J Artif Organs 2002; 25(3): 2039


Для цитирования:


Губарь Н.Я., Смирнов А.В., Суглобова Е.Д. СОВРЕМЕННЫЕ КОНВЕКЦИОННЫЕ МЕТОДЫ ТЕРАПИИ БОЛЬНЫХ С ХРОНИЧЕСКОЙ ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ. СООБЩЕНИЕ II. Нефрология. 2005;9(4):13-18. https://doi.org/10.24884/1561-6274-2005-9-4-13-18

For citation:


Gubar N.Y., Smirnov A.V., Suglobova E.D. MODERN CONVECTION METHODS OF THERAPY OF CHRONIC RENAL FAILURE PATIENTS. COMMUNICATION II. Nephrology (Saint-Petersburg). 2005;9(4):13-18. (In Russ.) https://doi.org/10.24884/1561-6274-2005-9-4-13-18

Просмотров: 28


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)